The global bronchial thermoplasty market was valued at USD 57.9 Million in 2018 and is anticipated to reach at USD 99.68 Billion by 2026, growing at a Compound annual growth rate (CAGR) of 153.8% from 2018 to 2026. Bronchial thermoplasty is a suitable treatment for some adults suffering from severe asthma. The treatment is done to make breathing easier by opening up the lungs and generate heat by using radio frequency energy to the airways wall. People suffering from severe asthma often find difficulty in breathing as because asthma causes the airways lining becomes swollen and inflamed, thereby making the airways narrower over time which makes it harder for air to pass through. In some people, bronchial thermoplasty can lower the symptoms of severe asthma while also reduce the possibility of asthma attacks. Growing communities of asthma on social media sites and people showing their curiosity towards bronchial thermoplasty (BT) is a key factor expected to augment the growth of the market during the forecast period.
The global bronchial thermoplasty market is segmented by age-group which includes 18-30 years, 30-50 years, and greater than 50 years. Out of the various age-groups, 30-50 years age group segment is anticipated to witness the largest market growth. More number of people belonging to this age group are suffering from severe asthma, and therefore, choose bronchial thermoplasty as the right option for treatment, as per suggested by their asthma specialist, which therefore makes the growth of this segment in the global bronchial thermoplasty market. Moving forward, in this treatment, BT reduces ASM (Airway Smooth Muscle) while also reduces bronchoconstriction and asthma exacerbations thereby improving the quality of life of an asthma patient. Bronchial thermoplasty treatment includes three sessions with at least three weeks interval. In the first session, the right lower lobe is treated, and after that in the second session, the left lower lobe is treated, followed by the treatment of both upper lobes in the third session. Rising aged population coupled with an increasing number of hospitals around the globe is expected to create a high growth opportunity for this market in the near future.
However, after the treatment, there are some possible side effects from the bronchial thermoplasty procedure. People may experience short-term wheezing problem, although it gets cleared within a week following the procedure. Such kind of side effects associated with the bronchial thermoplasty treatment is expected to affect the market growth during the projection period from 2017 to 2025.
The global bronchial thermoplasty market has been geographically segmented into Asia-Pacific, Europe, North America, Latin America, and the Middle East and Africa region. Among the other regions, North-America is anticipated to witness the largest market growth due to the growing number of individuals experiencing asthma attacks coupled with the increasing number of hospitalizations in the United States.
Some of the key players in the global bronchial thermoplasty market include Boston Scientific Corporation and McLaren Healthcare.
· 18 to 30
· 30 to 50
· Greater than 50
· North America
o Rest of Europe
· Asia Pacific
o Rest of Asia Pacific
· Middle East and Africa
o Saudi Arabia
o South Africa
o Rest of Middle East and Africa
· Latin America
o Rest of Latin America